^
    CANCER:

    Hairy Cell Leukemia





    Show legend
    Group by Gene:
    0
    CD20 inhibitor
    rituximab
    rituximab / hyaluronidase
    1
    BTK inhibitor
    ibrutinib
    zanubrutinib
    2
    BRAF inhibitor, BRAF V600E inhibitor
    vemurafenib
    3
    Bcl2 inhibitor, CD20 inhibitor
    venetoclax + rituximab
    4
    Protein synthesis inhibitor, CD22-targeted cytotoxin
    moxetumomab pasudotox
    5
    Adenosine deaminase inhibitor
    pentostatin
    6
    Bcl2 inhibitor
    venetoclax
    7
    Purinergic receptor P1 agonist
    cladribine
    8
    BRAF inhibitor, CD20 inhibitor
    dabrafenib + rituximab
    9
    BRAF inhibitor
    dabrafenib
    10
    MEK inhibitor, BRAF inhibitor
    trametinib + dabrafenib
    11
    BRAF inhibitor, BRAF V600E inhibitor, CD20 inhibitor
    vemurafenib + rituximab
    vemurafenib + obinutuzumab
    12
    Purinergic receptor P1 agonist, CD20 inhibitor
    rituximab + cladribine
    No biomarker
    BRAF V600E
    BRAF V600
    MYD88 L265P + BRAF V600E
    TP53 mutation
    KRAS mutation